Therapeutic Hypothermia Systems Market Growth, Share, Size and Analysis 2034
Therapeutic Hypothermia Systems Market Growth, Size, Trends Analysis- By Product Type, By Indication, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Jun-2025 | Report ID: MEDE2531 | Pages: 1 - 255 | Formats*: |
| Category : Medical Devices | |||
Therapeutic Hypothermia Systems Market Introduction and Overview
According to SPER Market Research, the Global Therapeutic Hypothermia Systems Market is estimated to reach USD 455.25 million by 2034 with a CAGR of 5.09%.
The report includes an in-depth analysis of the Global Therapeutic Hypothermia Systems Market, including market size and trends, product mix, Applications, and supplier analysis. The strong growth in this market is driven by the rising incidence of cardiovascular and neurological disorders, along with increasing awareness of the benefits of therapeutic hypothermia. As these disorders become more common, the range of medical conditions treated with therapeutic hypothermia is expanding. Clinical research and medical guidelines now frequently recommend hypothermic therapy for critical conditions like cardiac arrest, stroke, and traumatic brain injury, boosting demand for related systems. Therapeutic hypothermia systems are specialized medical devices designed to safely lower and maintain the body's temperature within a controlled range. This intentional cooling serves as an important treatment method for various health issues, especially those involving the heart and brain, by helping to protect and improve patient outcomes.
By Product Type:
The market is divided by product type into cooling devices, cooling catheters, cooling packs, and others. Cooling devices lead the segment due to their evolving technology and variety of cooling methods, including surface options like blankets, caps, and pads, as well as invasive intravascular catheters. This variety enables healthcare providers to customize treatment based on patient needs. Moreover, many cooling devices now feature closed-loop temperature control systems, which continuously monitor and adjust body temperature to maintain precise and effective therapeutic cooling.
By Indication:
The therapeutic hypothermia systems market is segmented by indication into neurology, cardiology, neonatal care, and others, with neurology leading in revenue. The rising incidence of ischemic strokes, where blood flow to the brain is blocked, has increased demand for these systems, as they help reduce brain injury and improve outcomes. Additionally, the expansion of neurological intensive care units supports wider use of therapeutic hypothermia for various neurological conditions, including neonatal hypoxic-ischemic encephalopathy, highlighting its broad applicability and driving market growth.
By End Use:
The therapeutic hypothermia systems market is segmented by end-use into hospitals, specialty clinics, and ambulatory surgical centers, with hospitals leading in revenue. The presence of intensive care units within hospitals supports widespread use of these systems to treat critical neurological and cardiovascular conditions. Hospitals with specialized neurological and cardiac care departments play a crucial role in market growth, as their focus on managing emergencies drives demand for therapeutic hypothermia systems tailored to specific patient needs in these specialized units.
Regional Insights:
The North American therapeutic hypothermia systems market is experiencing strong growth. The high prevalence of cardiovascular and neurological disorders in the region, including conditions like cardiac arrest, stroke, and traumatic brain injury, fuels demand for therapeutic hypothermia treatments. Additionally, significant investments in medical research and innovation drive advancements in these systems. Collaborations among research institutions, healthcare providers, and industry leaders contribute to the development of more effective and efficient cooling technologies, establishing North America as a key center for innovation in this market.
Market Competitive Landscape:
The global Therapeutic Hypothermia Systems Market is highly consolidated, with several prominent players shaping the industry. Key companies include: Asahi Kasei Corporation, Audax Management Company, LLC., Becton, Dickinson and Company, EM-MED Sp. z o.o. Sp. K., Gentherm Incorporated, International Biomedical Ltd, Phoenix Medical Systems Pvt. Ltd., Shenzhen Comen Medical Instruments Co., Ltd., Stryker Corporation, and Terumo Corporation.
Recent Developments:
In January 2024, SourceMark announced an expanded partnership with Gentherm Medical, a leading producer of patient temperature management systems. SourceMark has become the master supplier of select Gentherm product lines in the United States, including the Gelli-Roll reusable warming and cooling gel pad. This collaboration is expected to support Gentherm in strengthening its market presence.
In July 2023, ZOLL, a subsidiary of Asahi Kasei, announced an exclusive distribution agreement with BrainCool for the BrainCool System/IQool System and IQool System Pads in the U.S. and key European markets. The company is also working to expand distribution to select Asian markets. This partnership is expected to give ZOLL a competitive advantage and help broaden its customer base.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product Type, By Indication, By End Use |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | Asahi Kasei Corporation, Audax Management Company, LLC., Becton, Dickinson and Company, EM-MED Sp. z o.o. Sp. K., Gentherm Incorporated, International Biomedical Ltd, Phoenix Medical Systems Pvt. Ltd., Shenzhen Comen Medical Instruments Co., Ltd., Stryker Corporation, and Terumo Corporation. |
- Global Therapeutic Hypothermia Systems Market Size (FY 2021-FY 2034)
- Overview of Global Therapeutic Hypothermia Systems Market
- Segmentation of Global Therapeutic Hypothermia Systems Market By Product Type (Cooling devices, Cooling catheters, Cooling packs, Other product types)
- Segmentation of Global Therapeutic Hypothermia Systems Market By Indication, (Neurology, Cardiology, Neonatal care, Other indications)
- Segmentation of Global Therapeutic Hypothermia Systems Market By End-use, (Hospitals, Specialty clinics, Ambulatory surgical centers)
- Statistical Snap of Global Therapeutic Hypothermia Systems Market
- Expansion Analysis of Global Therapeutic Hypothermia Systems Market
- Problems and Obstacles in Global Therapeutic Hypothermia Systems Market
- Competitive Landscape in the Global Therapeutic Hypothermia Systems Market
- Details on Current Investment in Global Therapeutic Hypothermia Systems Market
- Competitive Analysis of Global Therapeutic Hypothermia Systems Market
- Prominent Players in the Global Therapeutic Hypothermia Systems Market
- SWOT Analysis of Global Therapeutic Hypothermia Systems Market
- Global Therapeutic Hypothermia Systems Market Future Outlook and Projections (FY 2025-FY 2034)
- Recommendations from Analyst
1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
6. Competitive Landscape
- 6.1. Global Therapeutic Hypothermia Systems Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Therapeutic Hypothermia Systems Market
7. Global Therapeutic Hypothermia Systems Market, By Product Type, (USD Million) 2021-2034
- 7.1. Cooling devices
- 7.2. Cooling catheters
- 7.3. Cooling packs
- 7.4. Other product types
8. Global Therapeutic Hypothermia Systems Market, By Indication, (USD Million) 2021-2034
- 8.1. Neurology
- 8.2. Cardiology
- 8.3. Neonatal care
- 8.4. Other indications
9. Global Therapeutic Hypothermia Systems Market, By End-use, (USD Million) 2021-2034
- 9.1. Hospitals
- 9.2. Specialty clinics
- 9.3. Ambulatory surgical centers
10. Global Therapeutic Hypothermia Systems Market, (USD Million) 2021-2034
- 10.1. Global Therapeutic Hypothermia Systems Market Size and Market Share
11. Global Therapeutic Hypothermia Systems Market, By Region, 2021-2034 (USD Million)
- 11.1. Asia-Pacific
- 11.1.1. Australia
- 11.1.2. China
- 11.1.3. India
- 11.1.4. Japan
- 11.1.5. South Korea
- 11.1.6. Rest of Asia-Pacific
- 11.2. Europe
- 11.2.1. France
- 11.2.2. Germany
- 11.2.3. Italy
- 11.2.4. Spain
- 11.2.5. United Kingdom
- 11.2.6. Rest of Europe
- 11.3. Middle East and Africa
- 11.3.1. Kingdom of Saudi Arabia
- 11.3.2. United Arab Emirates
- 11.3.3. Qatar
- 11.3.4. South Africa
- 11.3.5. Egypt
- 11.3.6. Morocco
- 11.3.7. Nigeria
- 11.3.8. Rest of Middle-East and Africa
- 11.4. North America
- 11.4.1. Canada
- 11.4.2. Mexico
- 11.4.3. United States
- 11.5. Latin America
- 11.5.1. Argentina
- 11.5.2. Brazil
- 11.5.3. Rest of Latin America
12. Company Profile
- 12.1. Asahi Kasei Corporation
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
- 12.2. Audax Management Company, LLC.
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
- 12.3. Becton, Dickinson and Company
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
- 12.4. EM-MED Sp. z o.o. Sp. K.
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
- 12.5. Gentherm Incorporated
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
- 12.6. International Biomedical Ltd
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
- 12.7. Phoenix Medical Systems Pvt. Ltd.
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
- 12.8. Shenzhen Comen Medical Instruments Co., Ltd.
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
- 12.9. Stryker Corporation
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
- 12.10. Terumo Corporation
- 12.10.1. Company details
- 12.10.2. Financial outlook
- 12.10.3. Product summary
- 12.10.4. Recent developments
- 12.11. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
The report includes an in-depth analysis of the Global Therapeutic Hypothermia Systems Market, including market size and trends, product mix, Applications, and supplier analysis
Therapeutic Hypothermia Systems Market is projected to reach USD 455.25 million by 2034, growing at a CAGR of of 5.09% during the forecast period.
Therapeutic Hypothermia Systems Market grew in Market size from 2025. The Market is expected to reach USD 455.25 million by 2034, at a CAGR of 5.09% during the forecast period.
Therapeutic Hypothermia Systems Market CAGR of 5.09% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Therapeutic Hypothermia Systems Market size is USD 455.25 million from 2025 to 2034.
Therapeutic Hypothermia Systems Market is covered By Product Type, By Indication, By End Use
The North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa is the highest Market share in the Therapeutic Hypothermia Systems Market .
Asahi Kasei Corporation, Audax Management Company, LLC., Becton, Dickinson and Company, EM-MED Sp. z o.o. Sp. K., Gentherm Incorporated, International Biomedical Ltd, Phoenix Medical Systems Pvt. Ltd., Shenzhen Comen Medical Instruments Co., Ltd., Stryker Corporation, and Terumo Corporation.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
